Total Funding
32
Total FundingGrant raised
Growth Score
pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area.
Nicola Redi: Non Executive Director- Giuseppe Tiberini: Director of operations
About the Company
Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.
Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
